| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $282.9M | -2.9% |
| Cost of Revenue | $103.1M | +2.0% |
| Gross Profit | $179.8M | -5.5% |
| R&D Expense | $33.8M | +1.7% |
| SG&A Expense | $60.3M | +4.6% |
| Operating Income | -$17.3M | -539.5% |
| Pre-tax Income | -$16.0M | -189.8% |
| Income Tax | -$1.5M | -128.3% |
| Net Income | -$14.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $145.5M | +44.9% |
| Accounts Receivable | $358.2M | -15.7% |
| Current Assets | $522.6M | -9.2% |
| Total Assets | $680.2M | -8.0% |
| Current Liabilities | $375.9M | -10.3% |
| Total Liabilities | $417.6M | -9.7% |
| Stockholders' Equity | $262.6M | -5.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $81.1M | +10.4% |
| Capital Expenditures | $14.3M | -18.5% |
| Investing Cash Flow | $6.1M | -72.8% |
| Financing Cash Flow | -$42.7M | +41.8% |
| Free Cash Flow | $66.7M | +19.5% |
| -215.7% |
| EPS (Basic) | -$0.31 | -224.0% |
| EPS (Diluted) | -$0.31 | -234.8% |